1. |
俞云松.超广谱β-内酰胺酶研究进展.中华医学杂志, 2006, 86:641-644.
|
2. |
Kitchel B, Rasheed JK, Patel JB, et al.Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States:clonal expansion of multilocus sequence type 258.Antimicrob Agents Chemother, 2009, 53:3365-3370.
|
3. |
Wei ZQ, Du XX, Yu YS, et al.Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.Antimicrob Agents Chemother, 2007, 51:763-765.
|
4. |
汤瑾, 李卿, 蒋燕群.对肺炎克雷伯菌碳青霉烯酶的研究进展.检验医学, 2010, 25:63-66.
|
5. |
李春辉, 吴安华.医疗机构耐药菌MDR、XDR、PDR的国际标准化定义专家建议(草案).中国感染控制杂志, 2011, 10:238-240.
|
6. |
Nordmann P, Cuzon G, Naas T.The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.Lancet Infect Dis, 2009, 9:228-236.
|
7. |
Falagas ME, Kastoris AC, Kapaskelis AM, et al.Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections:a systematic review.Lancet Infect Dis, 2010, 10:43-50.
|
8. |
Elemam A, Rahimian J, Mandell W.Infection with panresistant Klebsiella pneumoniae:a report of 2 cases and a brief review of the literature.Clin Infect Dis, 2009, 49:271-274.
|
9. |
许明, 林陈水, 付水星.替加环素的抗菌作用及药理学性质.国外医药(抗生素分册), 2006, 27:250-254.
|